Alessandro Barbone
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Alessandro
Contact Alessandro, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
First Demyelinating Attack in Children: a Twelve Year Single Center Cohort
Keywords Acquired Demyelinating Syndrome (ADS) Clinically Isolated Syndrome (CIS) Acute Demyelinating Encephalomyelitis (ADEM) Optic Neuritis (ON) Multiple Sclerosis (MS) Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Get full text access Log in, subscribe or purchase for full access. References 1. Abdel-Mannan, O.A. ∙ Manchoon, C. ∙ Rossor, T. ...
Unexpected Infective Endocarditis: Towards a New Alert for Clinicians
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Impella versus VA-ECMO for the treatment of patients with cardiogenic shock: the Impella Network Project - observational study protocol for cost-effectiveness and budget impact analyses | BMJ Open
Methods and analysis This will be an observational multicentre study. Patients with severe CS treated either with Impella (CP, 5.0 or 5.5) or with VA-ECMO will represent the study population in the prospective arm. This study population will be compared with a similar population of retrospective patients treated with VA-ECMO for severe CS, which will represent the control group. There is no randomisation procedure and all patients will be treated according to the standard of care per site.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alessandro
Contact Alessandro, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack